Mechanism of action and resistance to Trastuzumab Deruxtecan in patients with metastatic breast cancer: the DAISY trial
Fabrice André(Institut Gustave Roussy), Fernanda Mosele(Institut Gustave Roussy), Élise Deluche(Hôpital Dupuytren), Amélie Lusque(Institut Claudius Regaud), Loic Le-Bescond(Institut Gustave Roussy), Thomas Filleron(Institut Claudius Regaud), Yoann Pradat(Supélec), Agnès Ducoulombier(Centre Antoine Lacassagne), Barbara Pistilli(Institut Gustave Roussy), Thomas Bachelot(Centre Léon Bérard), F. Viret(Institut Paoli-Calmettes), Christelle Lévy(Centre François Baclesse), Nicolas Signolle(Institut Gustave Roussy), Alexia Alfaro(Institut Gustave Roussy), D. Tran(Institut Gustave Roussy), Ingrid Garberis(Institut Gustave Roussy), Hugues Talbot(Université Paris-Saclay), Stergios Christodoulidis(Institut Gustave Roussy), Maria Vakalopoulou(CentraleSupélec), Nathalie Droin(Institut Gustave Roussy), Aurelie Stourm(Institut Gustave Roussy), Maki Kobayashi(Daiichi Sankyo (United States)), Tomaya Kakegawa(Daiichi Sankyo (United States)), Ludovic Lacroix(Institut Gustave Roussy), Patrick Saulnier(Institut Gustave Roussy), Bastien Job(Institut Gustave Roussy), Marc Deloger(Institut Gustave Roussy), Marta Jimenez(UniCancer Group), Vianney Baris(Institut Gustave Roussy), Pierre Laplante(Institut Gustave Roussy), Patricia Kannouche(Centre National de la Recherche Scientifique), Virginie Marty(Institut Gustave Roussy), Magali Lacroix‐Triki(Institut Gustave Roussy), Véronique Dièras(Centre Eugène Marquis)
Cited by 7Open Access
Abstract
Related Papers
No related papers found
Powered by citation graph analysis